An LPL activator that increases LPL mRNA and LPL activity in adipose tissue, myocardium, and skeletal muscle; decreases plasma triglyceride concentration and increases plasma high-density lipoprotein cholesterol, resulting in inhibited development of atherosclerotic lesions in coronary arteries and aortas of rats and rabbits